FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/04/085353 [Registered on: 23/04/2025] Trial Registered Prospectively
Last Modified On: 15/04/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Other 
Public Title of Study   Effect of Arjun Manjistha combined and Ingudi in treatment of Melasma 
Scientific Title of Study   A clinico comparative study of Arjuna Twak (Terminalia arjuna Linn) with Manjistha (Rubia cordifolia Linn) Pralepa and Ingudi (Balanites aegyptiaca Del) Pralepa in the management of Vyanga WSR to Melasma 
Trial Acronym  nil 
Secondary IDs if Any  
Secondary ID  Identifier 
nil  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Neha Yadav 
Designation  PG Scholar 
Affiliation  Govt Auto Dhanwantri Ayurved Medical College 
Address  Department of Dravyaguna, Govt Auto Dhanwantri Ayurved Medical College Mangalnath Road Ujjain

Ujjain
MADHYA PRADESH
456001
India 
Phone  7974947234  
Fax    
Email  yneha9810@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Sunita D Ram 
Designation  Reader 
Affiliation  Govt Auto Dhanwantri Ayurved Medical College  
Address  Govt Auto Dhanwantri Ayurved Medical College Mangalnath Road Ujjain MP India

Ujjain
MADHYA PRADESH
456001
India 
Phone  9424014827  
Fax    
Email  drsunitadram72@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Sunita D Ram 
Designation  Reader 
Affiliation  Govt Auto Dhanwantri Ayurved Medical College  
Address  Department of Dravyaguna Govt Auto Dhanwantri Ayurved Medical College Mangalnath Road Ujjain MP India


MADHYA PRADESH
456001
India 
Phone  9424014827  
Fax    
Email  drsunitadram72@gmail.com  
 
Source of Monetary or Material Support  
Govt Auto Dhanwantri Ayurved Medical College Ujjain MP India 456001 
 
Primary Sponsor  
Name  Govt Auto Dhanwantri Ayurved Medical College  
Address  Govt Auto Dhanwantri Ayurved Medical College Mangalnath Road Ujjain MP India 456001 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
nil  nil 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Neha Yadav  Govt Auto Dhanwantri Ayurved Medical College   Dept of Dravyaguna Govt Auto Dhanwantri Ayurved Medical College Mangalnath Road Ujjain MP India 456001
Ujjain
MADHYA PRADESH 
7974947234

yneha9810@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICS COMMITTEE  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:L818||Other specified disorders of pigmentation. Ayurveda Condition: VYANGAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator ArmDrugClassical(1) Medicine Name: Ingudi , Reference: Rajamartand Mukhroga Adhikar 19, Route: Topical, Dosage Form: Lepa Churna, Dose: 5(g), Frequency: od, Bhaishajya Kal: , Duration: , anupAna/sahapAna: No, Additional Information:
(2) Medicine Name: 45 Days, Reference: No, Route: NA, Dosage Form: Lepa Churna, Dose: (), Frequency: , Bhaishajya Kal: , Duration: , anupAna/sahapAna: No, Additional Information:
2Intervention ArmDrugClassical(1) Medicine Name: Arjuna, Reference: Chakradutta Chikitsa 55/44, Route: Topical, Dosage Form: Lepa Churna, Dose: 3(g), Frequency: od, Bhaishajya Kal: , Duration: , anupAna/sahapAna: No, Additional Information:
(2) Medicine Name: 45 Days, Reference: No, Route: NA, Dosage Form: Lepa Churna, Dose: (), Frequency: , Bhaishajya Kal: , Duration: , anupAna/sahapAna: No, Additional Information:
(3) Medicine Name: Manjistha , Reference: Astang Sangrah Uttar 37/19, Route: Topical, Dosage Form: Lepa Churna, Dose: 3(g), Frequency: od, Bhaishajya Kal: , Duration: , anupAna/sahapAna: No, Additional Information:
(4) Medicine Name: 45 Days, Reference: No, Route: NA, Dosage Form: Lepa Churna, Dose: (), Frequency: , Bhaishajya Kal: , Duration: , anupAna/sahapAna: No, Additional Information:
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Patients presenting classical signs and symptoms of Vyanga
Patient willing to sign consent form
Patient fit for taking this medicine 
 
ExclusionCriteria 
Details  Melasma due to tuberculosis therapy and malignant cases allergy carcinoma burns herpes eczema psoriasis measles leprosy uncontrolled hormonal disease
patients who are reporting allergic history of trial drug 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
change in sign and symptoms of disease   change in sign and symptoms of disease at 7th week  
 
Secondary Outcome  
Outcome  TimePoints 
assessment of changes in clinical parameter after 15 days  1st follow up at 15th day
2nd follow up at 30th day
after treatment 45th day 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   30/04/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This is randomized interventional " A  Clinico Comparative study of Arjuna Twak (Terminalia arjuna Linn.) with Manjistha (Rubia cordifolia Linn.) Pralepa and Ingudi (Balanites aegyptiaca Del.) Pralepa in the management of Vyanga W.S.R to Melasma". Patients will be selected randomly for the study and will be divided into 2 groups. Each group will contain 30 patients. For the present study patients of either sex having the age group of 18 to 60 years who will present with complains  of sign and symptoms of Vyanga w.s.r. to Melasma will be selected irrespective of their religion and occupation etc. from the OPD of Government Dhanwantri Ayurveda medical College & Hospital Ujjain M.P. 
Close